In a small cohort of patients admitted for acute decompensated HF and HR >70 bpm, ivabradine has been shown as a safe and effective tool not only to reduce HR but also to improve the clinical status and reduce NT-proBNP levels (27). The gene discussed is NPPB; the disease is hydrops fetalis.